<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Bassini, Emanuele</dc:creator>
  <dc:creator>Gazzotti, Stefano</dc:creator>
  <dc:creator>Sannio, Filomena</dc:creator>
  <dc:creator>Lo Presti, Leonardo</dc:creator>
  <dc:creator>Sgrignani, Jacopo</dc:creator>
  <dc:creator>Docquier, Jean-Denis</dc:creator>
  <dc:creator>Grazioso, Giovanni</dc:creator>
  <dc:creator>Silvani, Alessandra</dc:creator>
  <dc:date>2020-05-12</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">The application of various isonitrile-based multicomponent reactions to protected (2-oxoethyl)boronic acid (as the carbonyl component)  is described. The Ugi reaction, both in the four components and in the four centers–three components versions, and the van Leusen  reaction, proved effective at providing small libraries of MIDA-protected β-aminoboronic acids. The corresponding free β-aminoboronic  acids, quantitatively recovered through basic mild deprotection, were found to be quite stable and were fully characterized, including by  11B-NMR spectroscopy. Single-crystal X-ray diffraction analysis, applied both to a MIDA-protected and a free β-aminoboronic acid  derivative, provided evidence for different conformations in the solid-state. Finally, the antimicrobial activities of selected compounds  were evaluated by measuring their minimal inhibitory concentration (MIC) values, and the binding mode of the most promising  derivative on OXA-23 class D β-lactamase was predicted by a molecular modeling study.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://susi.usi.ch/global/documents/319214</dc:identifier>
  <dc:identifier>https://n2t.net/ark:/12658/srd1319214</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/319214/files/sgrignani_antibiotics_2020.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.3390/antibiotics9050249</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1319214</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>CC BY</dc:rights>
  <dc:source>Antibiotics. - 2020, vol. 9, no. 5, p. 21 p</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Multicomponent reactions</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">β-amino boronic acids</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">β-lactamases</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Covalent docking</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/615</dc:subject>
  <dc:title xmlns:ns5="xml" ns5:lang="en">Isonitrile-based multicomponent synthesis of β-amino boronic acids as β-lactamase inhibitors</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
